The global ovarian cancer diagnostics market size is expected to reach USD 2.3 billion by 2028, registering a CAGR of 6.7% over the forecast period, according to the latest report by Reports and Data. Major factors driving market revenue growth are rising prevalence of ovarian cancer and increasing awareness about the importance of early detection of ovarian cancer.

Ovarian cancer is the seventh leading cause of death and morbidity in women worldwide. It is a complicated type of cancer that often affects women over the age of 65. Various studies have established the age group of 50–79 years as the average for diagnosis. Women have a one-in-75 risk of developing ovarian cancer and a one-in-one-hundred chance of dying from it. The prevalence of the disease varies by age and race, with the latter being more prevalent in less developed countries. Ovarian cancer incidence rates in Europe increased significantly from 1982 to 2008, increasing from 4.9 to 6.1 per 100,000 females. In the U.S., ovarian cancer accounted for 81.8 percent of all cancer cases in 2012.

Ovarian cancer is most common in women between the ages of 50 and 79. It is becoming more prevalent as the world's geriatric population grows and there is a greater emphasis on early detection and treatment, which is expected to accelerate ovarian cancer diagnostic market development. Increasing government investment in raising awareness about early cancer detection as well as increasing health-care spending would also propel business growth.

Obesity appears to play a significant role in the development of ovarian cancer. Other lifestyle choices that can raise the risk include smoking, drinking, and not having children. Since ovarian cancer is not easily detectable, women who are at risk of developing the disease must undergo routine testing to identify the disease early, allowing the market to expand.

Lack of knowledge about the exact causative factors and a late diagnosis of the disease are two major factors limiting development. In order to identify key genes or biochemical pathways that could be targeted for diagnosis and treatment, a better understanding of the underlying molecular processes is critical.

Some Key Highlights in the Report:

• Epithelial tumours segment is expected to account for largest market share over the coming years.
• Imaging techniques segment is expected to register a robust CAGR among the diagnosis type segments during the forecast period.
• Hospital laboratories segment accounted for largest revenue share among end user segments in the global market in 2020.
• Ongoing research and development in the ovarian cancer diagnostics market in North America will contribute to the relatively higher market share held by the region.
• Due to factors, such as improved healthcare infrastructure, increased disposable income, and increased awareness, Asia Pacific ovarian cancer diagnostics market is expected to expand at fastest pace during the forecast period.

Key Players covered in this report are

F. Hoffmann-La Roche Ltd.; GlaxoSmithKline plc; Johnson Johnson Services, Inc.; AstraZeneca plc; Siemens Healthcare GmbH; Quest Diagnostics Incorporated.; Thermo Fisher Scientific; Bio-Rad Technologies Inc.; and Abbott.

Cancer Type Outlook (Revenue, USD Billion; 2018 – 2028)

• Epithelial Tumour
• Germ Cell Tumour
• Stromal Cell Tumour
• Others

Diagnosis Type Outlook (Revenue, USD Billion; 2018 – 2028)

• Imaging
  • Ultrasound
  • CT Scan
  • MRI Scan
  • PET Scan
  • Others
• Blood Test
  • CA125
  • HER2
  • BRCA
  • CEA
  • ER PR
  • KRAS Mutation
  • Others
• Biopsy
• Others

End User Outlook (Revenue, USD Billion; 2018 – 2028)

• Hospital Laboratories
• Cancer Diagnostic Centers
• Research Institutes
• Others

Based on Region market is segmented into:

• North America
• Europe
• Asia-Pacific
• South America
• Middle East Africa

Request a sample Report of Ovarian Cancer Diagnostics Market @ https://www.reportsanddata.com/sample-enquiry-form/4093 

Major Points covered in this report are as below:

• The Ovarian Cancer Diagnostics industry development trends and marketing channels are analyzed. The feasibility of new investment projects are assessed and overall research conclusions offered.

• With the tables and figures, the report provides key statistics on the state of the industry and is a valuable source of guidance and direction for companies and individuals interested in the market.

• Development policies and plans, manufacturing processes and cost structures are also analyzed. This report also states import/export consumption, supply and demand figures, cost, price, revenue and gross margins.

• The Ovarian Cancer Diagnostics Market report provides key statistics on the market status of the Ovarian Cancer Diagnostics manufacturers and is a valuable source of guidance and direction for companies and individuals interested in the industry.

We can also provide the customized data for separate regions like North America, United States, Canada, Mexico, Asia-Pacific, China, India, Japan, South Korea, Australia, Indonesia, Singapore, Rest of Asia-Pacific, Europe, Germany, France, UK, Italy, Spain, Russia, Rest of Europe, Central South America, Brazil, Argentina, Rest of South America, Middle East Africa, Saudi Arabia, Turkey, Rest of Middle East Africa

About Reports and Data

Reports and Data is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target, and analyse consumer behaviour shifts across demographics, across industries, and help clients to make smarter business decisions. We offer market intelligence studies ensuring relevant and fact-based research across multiple industries, including Healthcare, Touch Points, Chemicals, Products, and Energy. We consistently update our research offerings to ensure our clients are aware of the latest trends existent in the market. Reports and Data has a strong base of experienced analysts from varied areas of expertise. Our industry experience and ability to develop a concrete solution to any research problems provides our clients with the ability to secure an edge over their respective competitors.